Study title:
Leuk Lymphoma. 1999 Aug;34(5-6):545-51.
Positron emission tomography (PET) for staging and evaluation of response to
treatment in patients with Hodgkin's disease.
Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, HÃr G,
Hoelzer D, Mitrou PS.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|